The French National Authority for Health (HAS) published new policy documents for regulations in the field of medical devices

18

Dec 2017

On 24th of November, the French National Authority for Health (HAS) organized meeting with manufacturers of medical devices with aim to explain the evaluation principles of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in order to accelerate the access for useful innovations to patients.

Additionally, CNEDiMTS considered the inclusion of dimension with quality of life assessment. CNEDiMTS proposed to manufacturers to document this dimension based on validated measurement scales. Thus, CNEDiMTS resorts to the evaluation that will be performed by patients.

On occasion to this meeting, several new policy documents were published in relation to regulation process of medical devices:

  • Connected medical devices: Guide for filing a file to the CNEDiMTS
    • It is a new guide for medical connected devices
    • Evaluation criteria for all medical devices are the same regardless the type of medical device. However, this guide aims to describe the expectations of CNEDiMTS regarding content of the file for submission of connected medical devices and provides a list of required documents
    • Current guide does not consider following devices:
      • Devices having no declared medical purpose
      • Connected medical devices that are not for individual use
      • Software intended for general use
      • Software intended for lifestyle or well-being uses that do not constitute medical devices
      • The guide for tools for assistance of prescription or dispensing, management software or administration of data (medical, financial, reimbursement).
  • CNEDiMTS's principles for evaluation of medical devices for individual use for access to reimbursement
    • This background paper aims to provide practical overview of principles of evaluation by CNEDiMTS. This document is mainly intended for manufacturers and for national specialized professional councils.
    • Document is divided into 3 parts:
      • Description of the regulatory framework for reimbursement of medical devices
      • Evaluation of the SA/ASA assessment during a registration and renewals of registration
      • Conditions of the evaluation (clinical investigation, criteria for evaluation, equivalence, comparators, etc.)

Additionally, other documents were updated:

See full information in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more